Sitafoxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide‑stimulated THP‑1 cells

• Material Type: 文書・図像類
• Title: Sitafoxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide‑stimulated THP‑1 cells
• Author/Editor: Sakamak, Ippei; Fukushi, Michika; Ohashi, Wakana; Tanaka, Yukie; Itoh, Kazuhiro; Tomihara, Kei; Yamamoto, Yoshihiro; Iwasaki, Hiromichi
• Author Heading: Sakamak, Ippei; Fukushi, Michika; Ohashi, Wakana; Tanaka, Yukie; Itoh, Kazuhiro; Tomihara, Kei; Yamamoto, Yoshihiro; Iwasaki, Hiromichi
• Publication, Distribution, etc.: Springer Nature
• Publication Date: 2021-12-17
• Publication Date (W3CDTF): 2021-12-17
• Alternative Title: Sitafoxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide‑stimulated THP‑1 cells
• Periodical title: Scientific Reports = Scientific Reports
• No. or year of volume/issue: 11 24154
• Volume: 11
• Issue: 24154
• ISSN (Periodical Title): ISSN : 2045-2322
• Text Language Code: eng
• Target Audience: 一般
• Note (General): Sepsis is a systemic reaction to an infection and resulting in excessive production of inflammatory cytokines and chemokines. It sometimes results in septic shock. The present study aimed to identify quinolone antibiotics that can reduce tumor necrosis factor alpha (TNFα) production and to elucidate mechanisms underlying inhibition of TNFα production. We identified quinolone antibiotics reduced TNFα production in lipopolysaccharide (LPS)-stimulated THP-1 cells. Sitafloxacin (STFX) is a broad-spectrum antibiotic of the quinolone class. STFX effectively suppressed TNFα production in LPS-stimulated THP-1 cells in a dose-dependent manner and increased extracellular signal-regulated kinase (ERK) phosphorylation. The percentage of intracellular TNFα increased in LPS-stimulated cells with STFX compared with that in LPS-stimulated cells. TNFα converting enzyme (TACE) released TNFα from the cells, and STFX suppressed TACE phosphorylation and activity. To conclude, one of the mechanisms underlying inhibition of TNFα production in LPS-stimulated THP-1 cells treated with STFX is the inhibition of TNFα release from cells via the suppression of TACE phosphorylation and activity. STFX may kill bacteria and suppress inflammation. Therefore, it can be effective for sepsis treatment.; source:https://www.nature.com/articles/s41598-021-03511-5
• Source: https://u-fukui.repo.nii.ac.jp/?action=repository_action_common_download&item_id=29211&item_no=1&attribute_id=22&file_no=1
• Access Restrictions: 限定公開
• Rights (production): cc by 4.0; CC BY
• Related Material (DOI): 10.1038/s41598-021-03511-5
• Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• Original Data Provider (Database): 福井大学 : 福井大学学術機関リポジトリ